This compound is primarily utilized in the field of asymmetric synthesis and catalysis. It serves as a chiral auxiliary or ligand in organic reactions, enabling the production of enantiomerically pure compounds. Its structure, featuring a trifluoromethyl group and a benzenesulfonamide moiety, enhances its effectiveness in stereoselective transformations, particularly in the synthesis of pharmaceuticals and fine chemicals. The compound's ability to induce high enantioselectivity makes it valuable in the development of active pharmaceutical ingredients (APIs) where chirality plays a critical role in biological activity. Additionally, it is used in research to explore new catalytic processes and optimize existing methodologies for industrial applications.